The trajectory of Viagra, originally marketed by copyright, presents a fascinating case study for stakeholders considering the healthcare landscape . Despite its groundbreaking success and creation of countless in earnings , the intellectual property lapse has opened the way for alternative medications, substantially eroding earnings opportunities.